Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
28.3 USD | +1.13% | -1.43% | +0.93% |
04:50pm | Royalty Pharma to Acquire Frexalimab Royalties, Milestones for $525 Million in Cash | MT |
02:18pm | Royalty Pharma's Q1 Net Income, Revenue Falls | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.93% | 12.62B | |
+32.87% | 698B | |
+26.51% | 568B | |
-4.49% | 358B | |
+19.27% | 328B | |
+3.55% | 283B | |
+16.34% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+8.65% | 165B |
- Stock Market
- Equities
- RPRX Stock
- News Royalty Pharma plc
- Transcript : Royalty Pharma plc Presents at The 6th Annual Evercore ISI HealthCONx Conference, Nov-28-2023 03